MALAT1 and diabetes mellitus: Our results demonstrated that the expression level of lncRNA MALAT1 in the LEAD group was significantly greater than that in the simple diabetes group, suggesting that MALAT1 plays a role in diabetic lower limb atherosclerotic disease.